Verve Therapeutics, Inc.

NasdaqGS:VERV Stock Report

Market Cap: US$503.5m

Verve Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:VERV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Dec 23BuyUS$18,000,000GV Management Company, LLCCompany1,800,000US$10.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of VERV?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,3890.00166%
Public Companies180,5970.215%
Individual Insiders4,390,0165.23%
General Public7,594,6279.05%
VC/PE Firms12,168,48914.5%
Institutions59,587,70171%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.5%.


Top Shareholders

Top 25 shareholders own 79.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.5%
GV Management Company, LLC
12,168,489US$73.0m17.4%6.59%
7.2%
ARK Investment Management LLC
6,040,476US$36.2m-14%0.29%
6.52%
The Vanguard Group, Inc.
5,471,930US$32.8m13.2%no data
5.29%
BlackRock, Inc.
4,435,481US$26.6m10.9%no data
4.74%
Federated Hermes, Inc.
3,980,372US$23.9m57.2%0.07%
4.61%
State Street Global Advisors, Inc.
3,866,764US$23.2m18%no data
3.81%
T. Rowe Price Group, Inc.
3,194,118US$19.2m50.4%no data
3.64%
FMR LLC
3,058,260US$18.3m-49%no data
3.59%
Casdin Capital, LLC
3,009,094US$18.1m1.84%1.6%
3.57%
James Singer
3,000,000US$18.0m-40%no data
3.09%
Nikko Asset Management Co., Ltd.
2,592,198US$15.6m8.12%0.01%
2.39%
Arch Venture Partners, L.P.
2,008,809US$12.1m0%0.93%
2.38%
Novo Holdings A/S
2,000,000US$12.0m0%0.01%
2.34%
JP Morgan Asset Management
1,966,537US$11.8m-18.5%no data
2.05%
Redmile Group, LLC
1,718,669US$10.3m112%0.44%
2.02%
Baker Bros. Advisors LP
1,691,530US$10.1m19.4%0.13%
1.49%
EcoR1 Capital, LLC
1,250,000US$7.5m0%0.25%
1.35%
Geode Capital Management, LLC
1,130,163US$6.8m7.34%no data
0.77%
BVF Partners L.P.
650,000US$3.9m0%0.1%
0.76%
Sekar Kathiresan
639,833US$3.8m0%no data
0.76%
BioImpact Capital LLC
638,163US$3.8m-25.6%0.74%
0.69%
Palo Alto Investors LP
575,817US$3.5m0%0.4%
0.62%
Woodline Partners LP
521,089US$3.1m-0.03%0.04%
0.59%
Northern Trust Global Investments
493,290US$3.0m5.78%no data
0.54%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
453,392US$2.7m154%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.